Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-mini-2024-07-18· OpenAIAi2 WildChat-4.8M (AI2)

Skip to main contentSkip to article\nBrought to you by:Iowa State University Library\nMy…

  1. User

    Skip to main contentSkip to article\nBrought to you by:Iowa State University Library\nMy account\nVeterinary Microbiology\nVolume 239, December 2019, 108488\nA putative transcription regulator involved in the virulence attenuation of an acriflavine-resistant vaccine strain of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas\nAuthor links open overlay panel, , , , ,\nhttps://doi.org/10.1016/j.vetmic.2019.108488Get rights and content\nHighlights\nThe frameshift mutagen acriflavine has been used to attenuate various pathogens.\n\nAn acriflavine-fast attenuated Erysipelothrix rhusiopathiae vaccine was analyzed.\n\nNext-generation sequencing revealed novel frameshift mutations.\n\nA putative transcriptional regulator involved in virulence was identified.\n\nThis is the first report of a virulence-related transcriptional regulator in E. rhusiopathiae.\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer

  2. Assistant

    报告:Erysipelothrix spp.的研究进展

    本报告基于一项关于Erysipelothrix rhusiopathiae的研究,特别是其在疫苗开发中的应用。Erysipelothrix rhusiopathiae是引起猪巴氏杆菌病的病原体,其致病性需要进一步研究以开发有效的疫苗。

    研究过程中应用了一种称为“丙烯荧光”的框移突变诱变剂,该方法已被用于减毒各种病原体。通过对一种对丙烯荧光耐药的减毒Erysipelothrix rhusiopathiae疫苗株进行分析,研究者们利用下一代测序技术揭示了新颖的框移突变。这些突变可能与该菌株的减毒特性密切相关。

    此外,研究还识别出一个与致病性相关的假定转录调节因子,这是Erysipelothrix rhusiopathiae中首次报告的与致病性相关的转录调节因子。这一发现可能为理解E. rhusiopathiae的致病机制提供新的视角,并为疫苗的开发奠定了理论基础。

    综上所述,研究不仅增强了我们对Erysipelothrix rhusiopathiae减毒疫苗的理解,还为未来研究提供了重要的参考。

    [End of Notes, Message #1] {{{ I_finished_papa!!! }}}

  3. User

    Skip to main contentSkip to article\nBrought to you by:Iowa State University Library\nMy account\nChemosphere\nVolume 171, March 2017, Pages 512-519\nCitric acid application for denitrification process support in biofilm reactor\nAuthor links open overlay panel, , , , , ,\nhttps://doi.org/10.1016/j.chemosphere.2016.12.099Get rights and content\nHighlights\nThe suitability of citric acid for aiding the denitrification in AnSBBR was proved.\n\nThe kinetic parameters were connected with the microbial communities structure.\n\nMicroorganisms from the Trichococcus genus developed at first (above 40%).\n\nPropionibacterium and Agrobacterium genera dominated in the second phase.\n\nThe biomass yield coefficient was ten times lower than in suspended biomass reactors.\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer

  4. Assistant

    报告:Erysipelothrix spp.的研究进展

    本报告基于一项关于Erysipelothrix spp.的研究,尽管提供的文本主要涉及其他微生物的研究,但我们可以从中提取相关的科学研究方法和结果,以便为Erysipelothrix spp.的研究提供参考。

    在研究中,使用了柠檬酸作为支持生物膜反应器中反硝化过程的添加剂。研究表明,柠檬酸在增强厌氧选择性生物膜反应器(AnSBBR)中的反硝化效果方面具有良好的适用性。研究还探讨了微生物群落结构与动力学参数之间的关系,发现Trichococcus属的微生物在初期占据了超过40%的比例,显示出其在反硝化过程中的重要性。

    随着反应的进行,Propionibacterium和Agrobacterium属的微生物在第二阶段占据主导地位。这一发现表明,不同微生物在反硝化过程中具有不同的生长阶段和优势。此外,研究还发现,生物质产量系数在生物膜反应器中比悬浮生物质反应器低十倍,提示在不同反应器中微生物的生长和代谢特性存在显著差异。

    虽然本报告的重点是Erysipelothrix spp.,但通过借鉴其他微生物的研究结果,我们可以更好地理解微生物在不同环境条件下的行为及其在生物处理过程中的应用潜力。

    [End of Notes, Message #2] {{{ I_finished_papa!!! }}}

  5. User

    Erysipelotrix rhusiopathiae: Case Report and Review of the Literature" /> Erysipelotrix rhusiopathiae: Case Report and Review of the Literature" />\nzeitschrift für orthopädie und unfallchirurgie\n130470\nZeitschrift für Orthopädie und Unfallchirurgie\nIowa State University 204 Parks Library\nRelated Journals\nAktuelle Rheumatologie\nRelated Books\nOrthopädie: Allgemein\nChirurgie: Unfallchirurgie\nOrthopädie: Operative Orthopädie\nAcupuncture/TCM\nHealth guide: back and intervertebral disc\nSubscribe to RSS\nPlease copy the URL and add it into your RSS Feed Reader.\n\nhttps://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000099.xml\nShare / Bookmark\nFacebook X Linkedin Weibo\nDownload PDF\nZ Orthop Unfall 2009; 147(6): 740-742 DOI: 10.1055/s-0029-1185917\nKniegelenk\n© Georg Thieme Verlag KG Stuttgart · New York\nKniegelenksinfekt mit Erysipelotrix rhusiopathiae: Fallbericht und Übersicht der internationalen Fachliteratur\nSeptic Arthritis Caused by Erysipelotrix rhusiopathiae: Case Report and Review of the LiteratureD.\n\nR. P. Neumann1 , M. Hafner1 , U. Dorn1\nFurther Information\nPublication History\nPublication Date: 28 August 2009 (online)\nAlso available at\nBuy Article Permissions and Reprints\nZusammenfassung\nEin 68 Jahre alter männlicher Patient wurde an unserer Abteilung mit dem Verdacht einer bakteriellen Kniegelenksinfektion links vorstellig, die durchgeführten diagnostischen Schritte bestätigten diese Verdachtsdiagnose und als Erreger konnte Erysipelothrix rhusiopathiae, der Erreger des Schweinerotlaufs, nachgewiesen werden.\n\nNach operativ-arthroskopischer Sanierung kombiniert mit intravenöser Antibiose, gefolgt von oraler Sequenzialtherapie über insgesamt 6 Wochen, konnte dem Patienten 6 Monate nach Diagnose eine Knietotalendoprothese mit unauffälligem postoperativem Verlauf implantiert werden.\n\nIn der internationalen Literatur finden sich nur insgesamt 4 andere Kasuistiken einer bakteriellen Gelenksinfektion mit Erysipelothrix rhusiopathiae.\n\nInsgesamt spricht somit auch diese Fallbeschreibung für eine pathogenetische Relevanz dieses Keims für den Menschen.\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer

  6. Assistant

    报告:Erysipelothrix rhusiopathiae的病例报告及文献综述

    本报告基于一例由Erysipelothrix rhusiopathiae引起的膝关节感染的病例,并对相关文献进行了综述。Erysipelothrix rhusiopathiae是引起猪巴氏杆菌病的病原体,近年来在人体感染中逐渐受到关注。

    在一项病例中,一名68岁的男性患者因怀疑左膝关节细菌感染而就诊。经过一系列诊断步骤,最终确认了Erysipelothrix rhusiopathiae为致病菌。患者接受了手术关节镜清创,并结合静脉抗生素治疗,随后进行了为期6周的口服序贯治疗。诊断后6个月,患者成功植入了膝关节全关节置换术,术后恢复良好。

    在国际文献中,仅有4例其他由Erysipelothrix rhusiopathiae引起的细菌性关节感染病例被报道。这表明该菌对人类的致病性具有一定的相关性,提示在临床实践中应对其引起的感染保持警惕。

    综上所述,Erysipelothrix rhusiopathiae在引起人类感染方面的病理相关性日益明显,值得进一步研究和关注。

    [End of Notes, Message #3] {{{ I_finished_papa!!! }}}

  7. User

    Journal of Veterinary Medicine, Series B\nVolume 47, Issue 6 p. 453-460\nFull Access\nInfluence of Antibiotics Used as Feed Additives on the Immune Effect of Erysipelas Live Vaccine in Swine\nK. Yamamoto,\nCorresponding Author\nK. Yamamoto\nCorresponding authorSearch for more papers by this author\nM. Takagi,\nM. Takagi\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nY.S.\n\nEndoh,\nY.S.\n\nEndoh\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nM. Kijima,\nM. Kijima\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nT. Takahashi,\nT. Takahashi\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nK. Yamamoto,\nCorresponding Author\nK. Yamamoto\nCorresponding authorSearch for more papers by this author\nM. Takagi,\nM. Takagi\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nY.S.\n\nEndoh,\nY.S.\n\nEndoh\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nM. Kijima,\nM. Kijima\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nT. Takahashi,\nT. Takahashi\nAddress of authors: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan;\nSearch for more papers by this author\nFirst published: 25 December 2001\nhttps://doi.org/10.1046/j.1439-0450.2000.00366.x\nCitations: 7\nSummary\nTo investigate the influence of antibiotics used as feed additives on the immune response to erysipelas live vaccine, the pig inoculation test was applied.\n\nAvilamycin, oxytetracycline quaternary salt, enramycin, virginiamycin and tylosin phosphate were selected as test antibiotics.\n\nFive experimental feeds containing each antibiotic at the highest concentration permitted for feed additives in Japan, and the basal diet lacking antibiotics were examined.\n\nTwenty-nine pigs were divided into six groups.\n\nAt first all the groups were fed with the antibiotic-free basal diet for 7 days, and then each group received the experimental feeds.\n\nOn the 14th day after feeding with test feeds all the pigs, except for one control pig in each group, were immunized with the vaccine and all the pigs were then challenge-exposed to a virulent strain of Erysipelothrix rhusiopathiae 14 days after vaccination.\n\nThe clinical response was observed every day for 14 days.\n\nIn all the groups, most of the vaccinated pigs did not develop any clinical signs of acute erysipelas after the challenge exposure, whereas non-vaccinated control pigs died or showed severe generalized erythema with profound depression and anorexia.\n\nNo differences in the protection against the challenge exposure were observed among the groups.\n\nTherefore, the present results suggest that these selected antibiotics would not interfere with the immune effect of the vaccine if given at the usual concentrations used for feed additives.\n\nIntroduction\nErysipelothrix rhusiopathiae is a Gram-positive bacterium and the causal agent of economically important swine erysipelas.\n\nIt is also an important pathogen in the field of public health as the causal agent of erysipeloid in humans ( Ewald, 1965; McCracken et al., 1973; Simerkoff and Rahal, 1973; Cabot, 1978).\n\nThe clinical symptoms of this disease in swine can be divided into three types; acute (septicemia), subacute (urticaria), and chronic (arthritis, lymphadenitis and endocarditis).\n\nIn Japan, to protect against swine erysipelas, an acriflavine-fast, attenuated strain of the bacterium, Koganei 65-0.15, obtained from a virulent strain after 65 passages on agar media containing 0.15 % acriflavine dyes, has been used as live vaccine for swine ( Seto et al., 1971).\n\nA local erythema following growth of the vaccine strain at the inoculation site is usually observed on the second or third day after vaccination in swine, indicating an adequate immune status.\n\nFrom around 1972, the occurrence of swine erysipelas decreased markedly with the increase in vaccine use.\n\nHowever, from about 1985, the occurrence of chronic endocarditis and arthritis in pigs increased, although piglets were generally vaccinated annually.\n\nThis increase may be due to interference with vaccine immunogenicity associated with the influence on the propagation of the vaccine strain in the cutis of pigs of the antibiotics that are widely administered in feeds in the field .\n\nAntibiotics added to feeds can be divided into two categories, namely ‘medicated antibiotics’, which are added to feeds upon veterinary prescription to treat bacterial diseases, and ‘feed-additive antibiotics’, which are widely used for growth purposes.\n\nOne of the requirements of feed-additive antibiotics is their comparatively low level of intestinal absorption and drug residues in livestock.\n\nIt is well known that the feed-additive antibiotics are highly effective against Gram-positive bacteria.\n\nSome types of feed-additive antibiotics could be essentially absorbed from the gut.\n\nSince the genus Erysipelothrix is highly susceptible to most of the antimicrobial agents, except for the aminoglycosides and sulphonamides, the veterinarians should avoid using medicated antibiotics before and after vaccination for 3–7 days.\n\nOn the other hand, feed-additive antibiotics have been used routinely and continuously for promoting porcine growth before and after vaccination without veterinary prescription.\n\nUntil now, little information had been available about the influence of the feed additives on the protective effect of the live vaccine.\n\nThe purpose of the present investigation was to determine the immunological effect of the feed-additive antibiotics on the immune response to erysipelas live vaccine by using a series of pig inoculation tests.\n\nMaterials and Methods\nAnimals\nTwenty-nine female or castrated male pigs, obtained through cross-breeding of Large White and Duroc pigs, were used when they were 2–3 months old.\n\nThey were conventionally farrowed and raised in confinement.\n\nSera of the pigs showed growth agglutinating (GA) ( Sawada et al., 1979) titres to Erysipelothrix of 16 or below.\n\nThe GA test was conducted, and titres were expressed as the reciprocal of the number with the highest dilution of serum with agglutination.\n\nVaccine\nLyophilized vaccine (live organisms) prepared from acriflavin-fast, attenuated E. rhusiopathiae, strain Koganei 65-0.15 (serovar 1a), was used.\n\nThe reconstituted vaccine contained 2 × 108 viable bacteria/ml.\n\nBacterial strains\nStrains Koganei 65-0.15, Fujisawa (serovar 1a) and ATCC19414T (the type strain, serovar 2) of E. rhusiopathiae were used for the minimal inhibitory concentration (MIC) test.\n\nIn the pig inoculation test, strain Fujisawa was used as the virulent strain for challenge exposure.\n\nAntibiotics\nZinc bacitracin (BC), enramycin (ER), thiopeptin (TPT), nosiheptide (NHT), virginiamycin (VGM), colistin sulphate (CL), oxytetracycline quaternary salt (OTC), tylosin phosphate (TS), kitasamycin (KT), sedecamycin (SCM), destomycin A (DM-A), hygromycin B (HM-B), avilamycin (AVM), efrotomycin (EFM) and bicozamycin (BCM) were used for the MIC test.\n\nThese antibiotics were authorized for use as feed additives for swine under the ‘Ministerial Ordinance Regarding the Standards of Feed and Feed Additives’ in Japan.\n\nDetermination of minimal inhibitory concentration\nMIC was determined by standard methods for agar dilution tests in Mueller-Hinton agar ( Ishiyama et al., 1968).\n\nAfter inoculation, agar plates were incubated for 48 h at 37°C.\n\nThe MIC was defined as the lowest concentration of antibiotics that prevented macroscopic growth.\n\nTwo-fold serial dilutions of antibiotic stock solutions were prepared so that the concentrations of the antibiotics ranged from 0.05 to 100 µg/ml (the concentrations of EFM ranged from 0.02 to 40 µg/ml).\n\nFeeds\nThe five experimental feeds consisted of the basal diet to which ER, VGM, OTC, TS, or AVM, respectively, were added at the highest concentration permitted under the ministerial ordinance for feed-additive antibiotics (ER, 20 g/t; VGM, 20 g/t; OTC, 70 g/t; TS, 44 g/t; AVM, 40 g/t).\n\nA sixth, antibiotic-free basal diet (feed without additives, hereafter referred to as ‘non-additive feed’) was also used.\n\nExperimental procedure\nTwenty-nine pigs were randomly divided into six groups of four or five pigs.\n\nAt first, all the groups received non-additive feed during the 7-day period of acclimatization, and then the test feeds were given to each group until the end of the experimental period.\n\nOn the 14th day after the administration of the test feeds, all the pigs, except for one control pig in each group, were inoculated subcutaneously with 1 ml of erysipelas live vaccine.\n\nLocal erythema at the site of inoculation with the vaccine was observed every day until the challenge exposure.\n\nEach group was challenge-exposed intracutaneously with the virulent strain Fujisawa (108 CFU/pig) at 14 days after the vaccination.\n\nThe local erythema at the injection site with the virulent strain Fujisawa and the clinical response were observed periodically, at least twice daily, for 14 days.\n\nTo determine the agglutinating antibody titre to Erysipelothrix, blood samples were obtained from the cranial vena cava of swine before vaccination, before challenge exposure and 14 days after challenge exposure.\n\nAfter 14 days of challenge exposure, all the surviving pigs were killed and an autopsy was performed to recover E. rhusiopathiae from the main organs (heart, lungs, liver, spleen, kidneys and arthrosynovia).\n\nIsolation of the bacteria from each sample and serotyping of bacteria identified as E. rhusiopathiae were performed by the method of Takahashi et al.\n\n(1989).\n\nTo determine whether the isolates consisted of the vaccine strain or the challenge strain, the isolates were tested for acriflavine resistance.\n\nThe local erythema at the site of inoculation with the vaccine, GA titre of porcine serum, clinical signs after challenge exposure and the recovery of the challenge strain were used as indicators of the immune effect of the vaccine.\n\nA protocol was designed to avoid the induction of adverse, stressful, or harsh conditions during the experiment for the animals exposed to E. rhusiopathiae.\n\nAll the pigs were cared for and the study was conducted in accordance with the National Veterinary Assay Laboratory Guide for the Care and Use of Laboratory Animals, and the Animal Welfare Acts.\n\nResults\nMinimal inhibitory concentration of E. rhusiopathiae\nAll three strains were highly susceptible to ER, TPT, NHT, VGM, TS, KT and AVM (MICs of 0.05–1.56 µg/ml), and moderately susceptible to OTC and EFM (MICs of 0.78–1.56 µg/ml and 0.02–20 µg/ml, respectively).\n\nBC, CL, SCM, DM-A, HM-B and BCM did not show any activity against the three strains ( Table 1).\n\nTable 1.\n\nMICs for strains of Erysipelothrix rhusiopathiae\nOn the basis of the MIC data and the relative frequency of use in pig production, we selected ER, VGM, OTC, TS and AVM for the present experiments.\n\nProtection of vaccinated swine against challenge exposure\nLocal erythema occurred at the vaccination site in all except two vaccinated pigs, and all the pigs exhibited high GA titres after vaccination, ranging from 32 to 256 ( Table 2).\n\nThe titres ranged from 64 to 512 after the challenge exposure.\n\nNone of the vaccinated pigs developed any clinical signs of acute swine erysipelas after the challenge exposure, and the challenge strain could not be recovered from the organs ( Tables 2 and 3).\n\nTable 2.\n\nImmune responses of swine inoculated with swine erysipelas live vaccine\nTable 3.\n\nClinical responses of swine to challenge exposure\nPig no.\n\n2 in the VGM-added feed group did not exhibit a local erythema at the site of inoculation with the vaccine ( Table 2).\n\nHowever, the GA titre of the pig rose to 128 after the vaccination and the pig did not develop any clinical signs after the challenge exposure ( Table 2 and 3).\n\nPig no.\n\n1 in the AVM-added feed group did not show a local erythema at the vaccine-inoculation site and no significant GA antibody response occurred after the vaccination ( Table 3).\n\nAfter challenge exposure, although the animal developed generalized erythema, the systemic response was weaker than that of the non-vaccinated control in the OTC-added feed group ( Table 3).\n\nNon-vaccinated control pigs in all the groups developed a local erythema at the inoculation site with the challenge strain from the first day after challenge exposure.\n\nOn the third day after the challenge exposure, the pigs, except for the pig in the OTC-added feed group, died of septicemia in the course of the acute phase.\n\nConsequently we could not kill these pigs later and attempt to recover the challenge strain.\n\nThe non-vaccinated control pig of in the OTC-added feed group developed severe generalized erythema with continuous depression on the third day after challenge exposure.\n\nE. rhusiopathiae was isolated only from the arthrosynovia of the pig ( Table 3).\n\nThe isolate showed a typical cellular morphology characteristic of E. rhusiopathiae and typical reactions in triple sugar iron agar slants and ‘test-tube brush’ growth in gelatin.\n\nSince the isolate belonging to serovar 1a was not resistant to acriflavine, the isolate was identified as the challenge strain.\n\nIn all the groups, the occurrence rates of the local erythema at the vaccination site were 75–100 % ( Table 4).\n\nGA titres in vaccinated pigs in all the groups were sufficient to protect against the challenge exposure.\n\nExcept for one pig in the AVM-added feed group, all the vaccinated pigs in all the groups were protected against the challenge exposure ( Table 4).\n\nTable 4.\n\nEffect of antibiotics as feed additives against swine erysipelas live vaccine\nDiscussion\nIn Japan, recently, mass outbreaks of erysipelas have occurred in pig herds.\n\nIn these farms, pigs which had received feeds containing tetracyclines for the treatment of bacterial pneumonia before and after vaccination with erysipelas live vaccine, died of acute septicemia due to oxytetracycline-resistant E. rhusiopathiae (unpublished data).\n\nThis response suggested that the administration of high concentrations of antibiotics to feeds without interruption before and after vaccination inhibits the propagation of the vaccine strain at the inoculation site in pigs, preventing vaccine take.\n\nThere is little information about the influence of the feed-additive antibiotics, which are continuously used in the field, on the protective effect of the vaccine.\n\nThus we investigated the immunological influence of feed-additive antibiotics on the vaccine.\n\nIn the present study, all three strains of E. rhusiopathiae were highly susceptible to ER, TPT, NHT, VGM, TS, KT and AVM, and moderately susceptible to OTC and EFM.\n\nER, VGM, OTC, TS and AVM are frequently used as feed additives in pig production and are effective against Gram-positive bacteria.\n\nIn general, the feed-additive antibiotics are hardly absorbed from the gut, whereas OTC and TS can be absorbed and circulate in the body.\n\nTherefore, it is assumed that they may interfere with the immune effect of the vaccine.\n\nAs a result, we selected ER, VGM, OTC, TS and AVM for the pig inoculation test.\n\nIn the pig inoculation test, pig no.\n\n2 in the VGM-added feed group did not show a local erythema at the inoculation site of the vaccine.\n\nThe GA titre of the pig increased enough to protect the pig against the challenge exposure with virulent strain Fujisawa, and it actually protected the pig against the challenge exposure, indicating that vaccine take had occurred in the pig.\n\nThe reason why the local erythema at the vaccination site, an indicator of immunity, did not develop was not clear, but the GA titre of the pig at the time of vaccination was relatively high (GA titre of 16) and consequently the vaccine strain might not have grown well.\n\nIn the AVM-added feed group, pig no.\n\n1 did not show a local erythema at the vaccine inoculation site and did not exhibit a significant antibody response.\n\nAfter challenge exposure, although the pig developed generalized erythema, the systemic response was not more severe than that of the non-vaccinated control in the OTC-added feed group.\n\nThe GA titre of the pig did not rise enough to protect it effectively against the challenge exposure but the vaccine might have had a slight effect on the pig.\n\nThe vaccination was successful in the remaining pigs of the group, inducing a protective effect against the challenge exposure.\n\nOn the basis of these results, it was assumed that AVM did not inhibit the vaccine take.\n\nIn summary in the pig inoculation tests, there was no significant difference between the groups fed with five additive feeds and the control group fed with non-additive feed in the antibody response, occurrence rate of the vaccine-related local erythema and protection rate against challenge exposure.\n\nIn addition, there was no interference with the immune response of the vaccine even in the groups that received feeds to which either OTC or TS had been added, which can be absorbed by the intestine.\n\nIn the preliminary experiments, we confirmed that OTC could be detected at a rate of 0.05 g/ml in the serum sample of the pigs which received OTC-added feed by using a high-performance liquid chromatographic method, with a detection limit of 0.05 g/ml in the serum (data not shown).\n\nFurther investigations are required to determine the concentrations of all the tested antibiotics in the porcine sera.\n\nIn conclusion, the present results suggest that some representative feed-additive antibiotics may not influence the actual immune effect of swine erysipelas live vaccine at the concentrations generally utilized for feed additives.\n\nAcknowledgements\nThe authors thank the staff of the Fertilizer and Feed Inspection Station for supplying the antibiotics used in the present study.\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer

  8. Assistant

    报告:饲料添加剂抗生素对猪巴氏杆菌活疫苗免疫效果的影响

    本报告基于一项研究,探讨了饲料添加剂抗生素对Erysipelothrix rhusiopathiae活疫苗免疫反应的影响。Erysipelothrix rhusiopathiae是引起猪巴氏杆菌病的病原体,具有重要的经济和公共卫生意义。

    研究中选用了几种抗生素作为饲料添加剂,包括阿维拉霉素、四环素季铵盐、恩拉霉素、维吉霉素和泰乐菌素。实验中使用了五种实验饲料,分别添加了上述抗生素,并与不含抗生素的基础饲料进行了比较。共29头猪被分为六组,所有组在实验开始的前7天均喂以不含抗生素的基础饲料,随后各组开始接受实验饲料。

    在喂养14天后,除了每组的一只对照猪外,其余猪均接种了Erysipelothrix rhusiopathiae活疫苗,并在接种后14天内暴露于致病菌株。观察结果显示,所有接种疫苗的猪在挑战暴露后未表现出急性巴氏杆菌病的临床症状,而未接种的对照猪则出现了严重的全身性红斑和抑郁症状,最终死亡。

    研究结果表明,所选的抗生素在通常用于饲料添加剂的浓度下不会干扰疫苗的免疫效果。尽管在某些情况下,局部红斑未能在接种部位出现,但这些猪的血清抗体水平仍足以提供保护。这一发现暗示,在饲料中常用的抗生素不会影响Erysipelothrix rhusiopathiae活疫苗的免疫反应。

    综上所述,本研究为理解饲料添加剂抗生素对猪巴氏杆菌疫苗免疫效果的影响提供了重要的实验数据,表明在适当浓度下,某些抗生素的使用不会对疫苗的免疫效果产生负面影响。

    [End of Notes, Message #4] {{{ I_finished_papa!!! }}}

  9. User

    Advertisement\nResearch Article\n26 May 2020\nShare on\nDevelopment of a Multiplex PCR-Based Assay for Rapid Serotyping of Erysipelothrix Species\nAuthors: Yoshihiro Shimoji, Kazumasa Shiraiwa, Haruka Tominaga, Sayaka Nishikawa, Masahiro Eguchi, Hirokazu Hikono, Yohsuke OgawaAuthors Info & Affiliations\nDOI: https://doi.org/10.1128/jcm.00315-20\n101,367\nMetrics\nTotal Citations10\nTotal Downloads1,367\nView all metrics\nCite\nPDF/EPUB\nABSTRACT\nThe Gram-positive bacterium Erysipelothrix rhusiopathiae is a zoonotic pathogen that causes erysipelas in a wide range of mammalian and avian species.\n\nHistorically, E. rhusiopathiae has been differentiated from other Erysipelothrix species by serotyping.\n\nAmong 28 serovars of Erysipelothrix species, specific serovars, namely, 1a, 1b, and 2 of E. rhusiopathiae, are associated mainly with the disease in pigs, poultry, and humans; however, other serovar strains are often simultaneously isolated from diseased and healthy animals, indicating the importance of isolate serotyping for epidemiology.\n\nThe traditional serotyping protocol, which uses heat-stable peptidoglycan antigens and type-specific rabbit antisera in an agar-gel precipitation test, is time-consuming and labor-intensive.\n\nTo develop a rapid serotyping scheme, we analyzed sequences of the 12- to 22-kb chromosomal region, which corresponds to the genetic region responsible for virulence of serovar 1a and 2 strains of E. rhusiopathiae, of the 28 serovars of Erysipelothrix species.\n\nWe confirmed that the serovar 13 strain lacks the genomic region and that some serovar strains possess very similar or the same genetic structure, prohibiting differentiation of the serovars.\n\nWe created 4 multiplex PCR sets allowing the simultaneous detection and differentiation of the majority of Erysipelothrix serovars.\n\nTogether with a previously reported multiplex PCR that can differentiate serovars 1a, 1b, 2, and 5, the multiplex PCR-based assay developed in this study covers all but one (serovar 13) of the reported serovars of Erysipelothrix species and should be a valuable tool for etiological as well as epidemiological studies of Erysipelothrix infections.\n\nINTRODUCTION\nErysipelothrix rhusiopathiae is a Gram-positive, non-spore-forming, rod-shaped bacterium and the standard species of the genus Erysipelothrix in the phylum Firmicutes (1).\n\nThe genus Erysipelothrix is composed of at least five species, E. rhusiopathiae, Erysipelothrix tonsillarum (2), Erysipelothrix inopinata (3), Erysipelothrix larvae (4), and Erysipelothrix piscisicarius sp.\n\nnov. (5), the last of which is pathogenic to fish and has been recently proposed as a new member of the genus.\n\nFurthermore, the existence of three other species, which are unnamed and tentatively referred to as Erysipelothrix sp.\n\nstrain 1, Erysipelothrix sp.\n\nstrain 2, and Erysipelothrix sp.\n\nstrain 3, has been suggested (6); however, Erysipelothrix sp.\n\nstrain 2 has now been confirmed to belong to E. piscisicarius sp.\n\nnov. (5).\n\nHistorically, based on heat-stable peptidoglycan antigens detected in a gel diffusion test, the four species E. rhusiopathiae (serovars 1a, 1b, 2, 4 to 6, 8, 9, 11, 12, 15 to 17, 19, 21, and N [serovar N lacks serovar-specific antigens]), E. tonsillarum (serovars 3, 7, 10, 14, 20, and 22), Erysipelothrix sp.\n\nstrain 1 (strain Pécs 56; serovar 13), and Erysipelothrix sp.\n\nstrain 2 (strain 715; serovar 18) have been differentiated by their serovars (2).\n\nTo date, new serovars have been assigned to E. rhusiopathiae (serovar 23) and E. tonsillarum (serovars 24 to 26).\n\nThe serovar of the new species E. piscisicarius sp.\n\nnov. has been determined; however, the serovars of E. inopinata and E. larvae have not yet been clarified.\n\nErysipelothrix species are ubiquitous in nature and have been isolated from a variety of animal species.\n\nAmong the genus Erysipelothrix species, E. rhusiopathiae is the main species that causes swine erysipelas, which may occur as acute septicemia or chronic polyarthritis and endocarditis, septicemic disease in turkeys, chickens, and dolphins, and chronic diseases in other farmed animals (7).\n\nIn humans, the manifestation of the disease is a skin disease known as erysipeloid, which can lead rarely to septicemia and endocarditis (8).\n\nRecently, E. rhusiopathiae infections in pigs and chickens have increased in many countries (9–12) and are also spreading into wildlife in arctic and boreal ecosystems, probably due to climate change (13, 14).\n\nEpidemiological and etiological studies have shown that specific E. rhusiopathiae serovars, namely, 1a, 1b, and 2, are isolated mainly from diseased pigs, chickens, and humans (9, 15–19).\n\nHowever, it is common that in pigs, various serovar strains with different virulence can be isolated from an individual animal, and healthy pigs can carry E. tonsillarum in their tonsils (20).\n\nSerotyping requires a full set of serovar reference strains and strain-specific rabbit antisera; therefore, only a few studies have examined serovars of isolates from wild animals in which a wide range of serovar strains appear to be prevalent.\n\nThus, serotyping of clinical isolates is important for understanding the epidemiology of infection in domesticated and wild animals and for monitoring serovar prevalence, indicating a clear need for rapid diagnostic methods in low-resource settings.\n\nRecently, the chromosomal region essential for serovar 1a antigenicity and virulence of E. rhusiopathiae was identified, and it was later confirmed that the sequences of the genetic region can be used for the differentiation of serovars 1a, 1b, 2, and 5 (21).\n\nIn this study, to develop a rapid serotyping system covering all serovars of Erysipelothrix species, we first measured genetic distances between Erysipelothrix species by average nucleotide identity (ANI) and analyzed the serovar-defining chromosomal region of 28 serovar strains of Erysipelothrix species for strain-specific sequences, which can be subsequently targeted by specific primers.\n\nMATERIALS AND METHODS\nBacterial strains.\n\nThe Erysipelothrix strains used to test the specificity of the primers are shown in Table S1 in the supplemental material, with the exception of the E. larvae LV19 and E. piscisicarius sp.\n\nnov. 15TAL0474 strains.\n\nErysipelothrix strains were grown at 37°C in brain heart infusion (BHI; Becton, Dickinson and Company, Baltimore, MD) supplemented with 0.1% Tween 80 (pH 8.0).\n\nSerotyping.\n\nSerotyping was determined by a double agar-gel precipitation test with autoclaved cell extracts and rabbit antiserum raised against formalin-killed cells of the reference strain, as described previously (22).\n\nSequence information and analysis.\n\nDraft genome sequences of Erysipelothrix strains were either retrieved from GenBank or generated using the Illumina HiSeq platform, as described previously (12).\n\nTrimmed reads were assembled using SPAdes (23), and the assembled contigs were evaluated using QUAST (24).\n\nGenetic relatedness among Erysipelothrix strains was analyzed by comparing the ANI using the ANI calculator (JSpecies ver.1.2.1, with default parameters) (25).\n\nIn E. rhusiopathiae serovar 1a and 2 strains, the chromosomal region between ERH_1438 and ERH_1451 was found to be responsible for serovar 1a and 2 antigenicity and virulence (26).\n\nUsing the IMCGE (in silico molecular cloning genomics edition) software (27), sequences of the corresponding and neighboring chromosomal regions of each Erysipelothrix serovar strain were analyzed, and primers were designed based on serovar-specific sequences (Table S3 in the supplemental material).\n\nFor 2 pairs of serovars, the 10 and 11 pair and the 2 (ATCC 19414) and 21 pair, which show similar genetic structures, DNA sequences from each locus were aligned with Clustal W (28) and visually searched for serovar-specific primer sequences.\n\nDNA methods.\n\nThe genomic DNA of Erysipelothrix strains was prepared as described previously (12), with the following modifications: after cells were lysed using 10% sodium dodecyl sulfate, the cell lysate samples were mixed with an equal volume of phenol-chloroform solution and centrifuged, and then DNA was recovered by ethanol precipitation.\n\nFor multiplex PCR assays, DNA was prepared using an alkaline boiling method, as previously described (15).\n\nBriefly, a single colony of each strain was suspended in 50 μl of 25 mM NaOH, incubated at 95°C for 5 min, and then neutralized by the addition of 4 μl of 1 M Tris-HCl (pH 8.0).\n\nThe suspension was centrifuged, and 1.0 μl of the supernatant was used for PCR.\n\nThe specificity of the PCR was assessed empirically using serovar reference strains, and then validation of the PCR assay was carried out by testing wild-type strains.\n\nPCR was performed using Quick Taq HS DyeMix (Toyobo, Osaka, Japan) and a T-100 thermal cycler (Bio-Rad, CA, USA).\n\nBriefly, amplification reaction mixtures were prepared according to the manufacturer’s recommendations but scaled down to 25 μl per reaction.\n\nFor multiplex PCR assays, the concentration of primers was changed according to the sizes of DNA fragments.\n\nThe composition of the multiplex PCR mixtures is shown in Table S4 in the supplemental material.\n\nThe PCR was performed under the following conditions: initial denaturation at 94°C for 2 min, followed by 3 amplification steps (30 cycles) consisting of 94°C for 30 s, 60°C for 30 s, and 68°C for 1 min.\n\nData availability.\n\nSequence data generated in this study have been deposited in the NCBI Sequence Read Archive (BioProject accession no.\n\nPRJNA607040).\n\nRESULTS AND DISCUSSION\nThe sequences of the chromosomal region from ERH_1438 through ERH_1451, which were identified as being responsible for virulence and antigenicity of the serovar 1a strain (Fujisawa), and the corresponding genomic regions of other serovar strains are shown in Fig.\n\n1.\n\nSequence analysis revealed that the serovar 13 strain (strain Pécs 56; Erysipelothrix sp.\n\nstrain 1) lacks the corresponding genetic region.\n\nWe confirmed that the serovar 13 strain shares 84.16 to 85.20% ANI with the strains of the species E. rhusiopathiae, E. tonsillarum, and Erysipelothrix sp.\n\nstrain 2 (strain 715; serovar 18) but shares 96.17% ANI with E. inopinata (Table S1), strongly suggesting that Erysipelothrix sp.\n\nstrain 1 (the serovar 13 strain) and E. inopinata are the same species.\n\nIn this study, we could not identify the serovar-defining region in these strains, and therefore, the serovar 13 strain and E. inopinata were excluded from the assays.\n\nFIG 1\nAs has been previously observed with the serovar 2/15 strains, which were reactive with both serovar 2 and 15 antisera and positive in a serovar 2-detecting PCR assay (21), it was found that three strain pairs of serovars 10 and 11, serovars 7 and 14, and the E. rhusiopathiae ATCC 19414 type strain, which has been regarded as serovar 2, and serovar 21 possess very similar or the same genetic structure (Fig.\n\n1).\n\nIt has been reported that antibody cross-reaction occurred between serovars 7 and 14 (29, 30).\n\nWe observed this cross-reaction and confirmed that anti-serovar 10 serum is partially reactive with the serovar 11 antigen and that anti-serovar 21 serum is strongly reactive with the ATCC 19414 antigen (our unpublished data).\n\nDue to the difficulty in finding serovar-specific sequences for differentiation between serovars 10 and 11 and between serovars 7 and 14, primers were designed to detect together the strain pairs of serovars 10 and 11 (10/11) and serovars 7 and 14 (7/14) (Table S3).\n\nFor other Erysipelothrix serovar strains, primers were designed to specifically detect each serovar.\n\nFor convenience, multiplex PCR assays were developed to detect the following four serovar groups: group 1 (serovars 6, 8, 9, 15, and 21), group 2 (serovars 4, 12, 17, 19, and 23), group 3 (serovars 3, 10/11, 16, 24, and 26), and group 4 (serovars 7/14, 18, 20, 22, and 25) (Fig.\n\n2).\n\nEach set contained five primer sets that amplified products of correct different sizes for comprehensible differentiation.\n\nValidation of the assays with a total of 254 strains using boiled DNA as the template showed no extra bands, confirming the specificity and usability of the assays (Table 1).\n\nIn the assays, untypeable strains, which are most likely the same as serovar N strains (26), were determined to be either serovar 6, serovar 8, or serovar 21, suggesting that these strains had mutation(s) in the serovar-defining chromosomal region and originated from the respective serovar strains.\n\nThus, together with the multiplex PCR that can differentiate serovars 1a, 1b, 2, and 5, the described multiplex PCR assays cover all reported serovars of Erysipelothrix species except serovar 13 (Erysipelothrix sp.\n\nstrain 1), which is most likely the same species as E. inopinata.\n\nWe believe that the multiplex PCR-based serotyping method should be useful in investigating the disease transmission potential between humans, livestock, and wildlife.\n\nHowever, the number of strains tested was limited for some serovars, and therefore, it is important to verify the system using strains from a variety of different sources.\n\nFIG 2\nTABLE 1\nIn Erysipelothrix species, serovar switching has been suggested, probably due to the acquisition of foreign genes by horizontal gene transfer, as indicated by G+C contents of the serovar-defining region that were different from those in other parts of the genome (26).\n\nAs observed in Fig.\n\n1, the hypothesis is further supported by the finding that transposable elements are located within the regions in seven serovar strains, including the ATCC 19414 strain, the type strain of E. rhusiopathiae.\n\nPreviously, it was confirmed that Erysipelothrix sp.\n\nstrain 2 (strain 715) (serovar 18) and the new species E. piscisicarius sp.\n\nnov. are the same species.\n\nHowever, the E. piscisicarius sp.\n\nnov. 15TAL0474 strain has been shown to be a serovar 5 strain (31).\n\nThus, in some strains, the serovar is not strictly associated with whole-genome-based classification of Erysipelothrix species (6).\n\nAlthough serovar 1a, 1b, and 2 strains of E. rhusiopathiae are associated mainly with disease in animals and the role of serovar-defining antigen(s) in virulence in these serovars has been clarified (26), the underlying mechanisms remain largely unknown.\n\nIt is highly possible that combination(s) of the serovar-defining antigen(s) and other virulence-associated antigen(s) may be necessary to cause the disease.\n\nFor etiological and epidemiological studies, the use of the described multiplex PCR method in combination with other molecular analyses, including spa typing (32–34), may be important.\n\nACKNOWLEDGMENTS\nThis work was supported by a grant from the National Agriculture and Food Research Organization (to Y.S.).\n\nWe declare no conflicts of interest.\n\nSupplemental Material\nFile (jcm.00315-20-s0001.xlsx)\nASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article.\n\nThe authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files.\n\nPlease contact the corresponding author directly for reuse.\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer

  10. Assistant

    报告:基于多重PCR的Erysipelothrix物种快速分型检测方法的开发

    本研究旨在开发一种基于多重PCR的快速分型检测方法,以便对Erysipelothrix物种进行快速分型。Erysipelothrix rhusiopathiae是一种革兰氏阳性细菌,是引起多种哺乳动物和鸟类发生巴氏杆菌病的病原体。E. rhusiopathiae的28个血清型中,特定的血清型1a、1b和2主要与猪、家禽和人类的疾病相关。然而,其他血清型的菌株常常同时从病态和健康动物中分离出来,这表明对分离株进行血清分型在流行病学研究中的重要性。

    传统的血清分型方法使用热稳定的肽聚糖抗原和特异性兔抗血清进行琼脂凝胶沉淀测试,过程耗时且劳动强度大。为此,研究者分析了与E. rhusiopathiae血清型1a和2菌株的毒力相关的12至22 kb染色体区域的序列,确认血清型13菌株缺乏该基因组区域,并且一些血清型菌株具有非常相似或相同的遗传结构,导致无法区分这些血清型。

    研究团队创建了4个多重PCR试剂盒,能够同时检测和区分大多数Erysipelothrix血清型。结合先前报道的能够区分血清型1a、1b、2和5的多重PCR,该检测方法覆盖了除血清型13之外的所有已报道Erysipelothrix物种的血清型,预计将成为Erysipelothrix感染的病因学和流行病学研究的重要工具。

    本研究的结果表明,开发的多重PCR分型方法在快速检测Erysipelothrix物种及其血清型方面具有重要的应用潜力,尤其是在资源有限的环境中。

    [End of Notes, Message #5] {{{ I_finished_papa!!! }}}

  11. User

    As a library, NLM provides access to scientific literature.\n\nInclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.\n\nLearn more: PMC Disclaimer | PMC Copyright Notice\nVet Med Sci.\n\n2021 Nov; 7(6): 2290–2302.\n\nPublished online 2021 Aug 14. doi: 10.1002/vms3.599\nPMCID: PMC8604140\nPMID: 34390537\nZoonotic pathogens in wild muskoxen (Ovibos moschatus) and domestic sheep (Ovis aries) from Greenland\nRebecca P. K. D. Berg, 1 , 2 C. Rune Stensvold, 3 Pikka Jokelainen, 3 Anna K. Grønlund, 3 Henrik V. Nielsen, 3 Susan Kutz, 4 and Christian M.O.\n\nKapel 1\nRebecca P. K. D. Berg\n1 Department of Plant and Environmental Sciences, University of Copenhagen, Denmark\n2 Department of Birds and Mammals, Greenland Institute of Natural Resources, Nuuk Greenland\nFind articles by Rebecca P. K. D. Berg\nC. Rune Stensvold\n3 Department of Bacteria, Parasites & Fungi, Infectious Disease Preparedness, Statens Serum Institut, Copenhagen Denmark\nFind articles by C. Rune Stensvold\nPikka Jokelainen\n3 Department of Bacteria, Parasites & Fungi, Infectious Disease Preparedness, Statens Serum Institut, Copenhagen Denmark\nFind articles by Pikka Jokelainen\nAnna K. Grønlund\n3 Department of Bacteria, Parasites & Fungi, Infectious Disease Preparedness, Statens Serum Institut, Copenhagen Denmark\nFind articles by Anna K. Grønlund\nHenrik V. Nielsen\n3 Department of Bacteria, Parasites & Fungi, Infectious Disease Preparedness, Statens Serum Institut, Copenhagen Denmark\nFind articles by Henrik V. Nielsen\nSusan Kutz\n4 Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Canada\nFind articles by Susan Kutz\nChristian M.O.\n\nKapel\n1 Department of Plant and Environmental Sciences, University of Copenhagen, Denmark\nFind articles by Christian M.O.\n\nKapel\nAuthor information Copyright and License information PMC Disclaimer\n1 Department of Plant and Environmental Sciences, University of Copenhagen, Denmark\n2 Department of Birds and Mammals, Greenland Institute of Natural Resources, Nuuk Greenland\n3 Department of Bacteria, Parasites & Fungi, Infectious Disease Preparedness, Statens Serum Institut, Copenhagen Denmark\n4 Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Canada\nRebecca P. K. D. Berg, Email: kd.uk.nelp@bpr.\n\nCorresponding author.\n\nCopyright © 2021 The Authors.\n\nVeterinary Medicine and Science published by John Wiley & Sons Ltd.\n\nThis is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.\n\nGo to:\nAbstract\nThe present study aimed to estimate the prevalence of zoonotic pathogens Giardia duodenalis, Cryptosporidium spp., Toxoplasma gondii and Erysipelothrix in muskoxen (Ovibos moschatus) and sheep (Ovis aries) from Greenland.\n\nIn 2017 and 2018, faecal samples were collected from wild muskoxen from three distinct populations (Zackenberg, Kangerlussuaq, and Ivittuut) and from domestic sheep from southwest Greenland.\n\nBlood samples were collected from muskoxen from Kangerlussuaq and Ivittuut and from sheep.\n\nFaecal samples were tested for specific DNA of G. duodenalis and Cryptosporidium spp., and blood samples were tested for antibodies against T. gondii and Erysipelothrix.\n\nThe estimated prevalence of G. duodenalis was 0% (0/58), 17% (7/41) and 0% (0/55) in muskoxen from Zackenberg, Kangerlussuaq and Ivittuut, respectively, and 37% (16/43) in sheep.\n\nThe estimated prevalence of Cryptosporidium was 0% (0/58), 2% (1/41), 7% (4/55) in muskoxen from Zackenberg, Kangerlussuaq, Ivittuut, respectively, and 2% (1/43) in sheep.\n\nNeither Giardia nor Cryptosporidium were detected in winter samples (0/78).\n\nOf the positive samples, Giardia from one muskox sample only was successfully typed as G. duodenalis assemblage A, and Cryptosporidium from two muskoxen was successfully typed as C. parvum, subtype IIdA20G1e.\n\nThe estimated T. gondii seroprevalence was 2% (1/44) and 0% (0/8) in muskoxen from Kangerlussuaq and Ivittuut, respectively, and 1% (1/155) in sheep.\n\nThe estimated Erysipelothrix seroprevalence was 2% (1/45) and 13% (1/8) in muskoxen from Kangerlussuaq and Ivittuut, respectively, and 7% (10/150) in sheep.\n\nThe results of this study add to the scarce knowledge on zoonotic pathogens in the Arctic.\n\nKeywords: arctic regions, epidemiology, ruminants, serology, zoonoses\nWe estimated the prevalence of four zoonotic agents – Giardia duodenalis, Cryptosporidium, Toxoplasma gondii and Erysipelothrix – in muskoxen (Ovibos moschatus) and sheep (Ovis aries) from Greenland and reported the first molecular detection of G. duodenalis and C. parvum in Greenland.\n\nThe results add to the scarce knowledge on zoonotic pathogens in the Arctic.\n\nGo to:\n1.\n\nINTRODUCTION\nEndemic and emerging zoonotic infectious diseases have received increasing attention during the last few decades (Cunningham et al., 2017).\n\nClimate warming and other environmental changes (AMAP, 2019) may alter the distribution and transmission patterns of a range of zoonotic agents in the Arctic (Davidson et al., 2011; MacPhee & Greenwood, 2013; Thompson et al., 2010), which in turn may impact the health of Arctic animals and Arctic subsistence hunters (Hoberg et al., 2012; Jenkins et al., 2013).\n\nHowever, data on the distribution of zoonotic pathogens in Arctic key subsistence animals are limited (AMAP, 2015), and studies on zoonotic agents in humans and terrestrial mammals from Greenland are few and scattered (e.g.\n\nCarlsson et al., 2019; Clausen & Hjort, 1986; Møller et al., 2010; Raundrup et al., 2015; Sonne et al., 2018).\n\nSpecifically, no data are available on the prevalence of Giardia duodenalis, Cryptosporidium spp.\n\nand Erysipelothrix rhusiopathiae in muskoxen (Ovibos moschatus) and sheep (Ovis aries) in Greenland, while a few serological surveys for T. gondii have been performed (Bille, 1974; Clausen & Hjort, 1986).\n\nHowever, exposure to or shedding of these pathogens have been reported in muskoxen and sheep elsewhere within the Arctic and Subarctic range (Jenkins et al., 2013; Kutz et al., 2000, 2008, 2012; Mavrot et al., 2020; Olsen et al., 2019; Robertson et al., 2010).\n\nThe protozoan parasites Giardia and Cryptosporidium are transmitted via the faecal–oral route, for example, through the intake of food or water contaminated with faeces containing the cysts or oocysts (Smith et al., 2007) and may cause diarrheal disease in humans and domestic animals worldwide; however, their clinical impact on most wildlife hosts is largely unknown (Appelbee et al., 2005; Jenkins et al., 2013; Kutz et al., 2009; Savioli et al., 2006).\n\nToxoplasma gondii is a globally distributed protozoan parasite, with wild and domestic felids as the only known definitive hosts, and with a wide range of warm‐blooded animals, including humans, as intermediate hosts (Dubey, 2010).\n\nInfection typically occurs through ingestion of sporulated oocysts in the environment or viable tissue cysts in the tissues of infected animals, but transplacental transmission also occurs (Dubey, 2010).\n\nThe infection is often subclinical in immunocompetent individuals but it may result in severe disease, especially in immunocompromised hosts and offspring (Dubey, 2010).\n\nErysipelothrix rhusiopathiae is a zoonotic bacterium with a global distribution and a wide range of hosts (Forde et al., 2016; Wang et al., 2010).\n\nIt is commonly known as an opportunistic pathogen in pigs, poultry and humans, and a relatively common cause of polyarthritis in sheep (Ersdal et al., 2015).\n\nAdditionally, it has been associated with abortions in ewes (Fthenakis et al., 2006).\n\nTransmission occurs through contact with contaminated materials or soil (Wang et al., 2010).\n\nErysipelothrix rhusiopathiae can cause localised cutaneous infections and systemic infections in humans (Wang et al., 2010).\n\nFurthermore, E. rhusiopathiae has been associated with widespread mortality events in Arctic ungulates (Forde et al., 2016; Kutz et al., 2015; Mavrot et al., 2020) and its presence in Arctic wildlife has recently been recognised as a potential public health concern (Groeschel et al., 2019).\n\nImpacts\nWe estimated the prevalence of four zoonotic agents—Giardia duodenalis, Cryptosporidium, Toxoplasma gondii, and Erysipelothrix—in muskoxen (Ovibos moschatus) and sheep (Ovis aries) in Greenland.\n\nWe report the first molecular detection of G. duodenalis and C. parvum in Greenland.\n\nThe results add to the scarce knowledge on zoonotic pathogens in the Arctic.\n\nMuskoxen and sheep are known hosts to several zoonotic agents.\n\nIn the 1960s, muskoxen were translocated from their native range in northeast Greenland (NEG) to mid‐west Greenland (MWG) (Cuyler et al., 2020).\n\nSubsequent translocations have distributed muskoxen along the west coast of Greenland, and there are now nine populations, some of which overlap the sheep‐farming area in southwest Greenland (SWG) (Cuyler et al., 2020).\n\nThe majority of the muskox populations are regulated annually, and muskox meat is consumed without prior veterinary inspection or control (Naalakkersuisut, 2020).\n\nThe present study aimed to estimate the prevalence of G. duodenalis, Cryptosporidium spp., T. gondii and Erysipelothrix in wild muskoxen and domestic sheep in Greenland.\n\nGo to:\n2.\n\nMATERIALS AND METHODS\n2.1.\n\nLocations and animal host populations\nThe study included muskox samples from three regions in Greenland, collected during two seasons (Figure 1): Samples collected during summer from Zackenberg (NEG), Kangerlussuaq (MWG) and Ivittuut (SWG), and winter samples from Kangerlussuaq.\n\nMuskoxen were divided into the following age groups: calves (<1 year), subadults (1 and <3 years) and adults (3 years).\n\nCalves are usually born in May or June; thus, they were 1–3 and 8–10 months old during summer and winter sampling, respectively.\n\nSheep samples were collected in SWG during the autumn, the sheep were divided into two age groups: Lambs (<1 year) and adults (1).\n\nOpen in a separate window\nFIGURE 1\nMap of Greenland showing the sampling locations and seasons for the study of zoonotic pathogens in muskoxen (Ovibos moschatus) and domestic sheep (Ovis aries).\n\nThe map was created in QGIS software version 2.18 (QGIS.org, 2019)\nNortheast Greenland, where Zackenberg (74°28′N) is located, has been populated by muskoxen for at least 4500 years (Campos et al., 2010).\n\nHuman activity in this part of Greenland is limited.\n\nThe Kangerlussuaq (67°01′N) muskox population on the west coast was introduced from NEG in the 1960s and is the largest in Greenland (Cuyler et al., 2020).\n\nThe area around Kangerlussuaq is used by tourists and locals for recreational activities and commercial hunting of muskoxen and caribou (Rangifer tarandus).\n\nThe Ivittuut muskox population was introduced from Kangerlussuaq in the 1980s (Cuyler et al., 2020) and is found around the Arsuk fiord (61°14′N), where it shares its range with caribou.\n\nApproximately 130 km south of Arsuk lies Greenland's northernmost sheep farms.\n\nThe sheep, belonging to the 37 separate sheep farms in SWG (Grønlands Statistik, 2020), are typically free‐roaming in the mountain grazing areas until the slaughtering period in September/October.\n\nThe area is used for commercial hunting, farming, and recreational activities.\n\n2.2.\n\nFaecal sampling\nFaecal samples were collected from wild muskoxen (NEG, MWG and SWG) and sheep (SWG) in 2017 and 2018 (Table 1).\n\nFaecal consistency was not recorded.\n\nNeither was weight or other indication of body condition of the sampled animals.\n\nTABLE 1\nThe number of samples included in the study of selected zoonotic organisms in wild muskoxen (Ovibos moschatus) and free‐roaming domestic sheep (Ovis aries) in Greenland by location, age group, a sampling method and year of sampling.\n\nSamples were collected in three regions of Greenland: northeast (Zackenberg), mid‐west (Kangerlussuaq) and southwest (Ivittuut and Narsaq)\nSpecies/season/ location/age group No.\n\nof faecal samples Sampling method (D/R) b No.\n\nof serology samples Sampling method (ST/FP) c Year of sampling Muskox Summer Zackenberg Calf 10 10/0 0 NA d 2017 Subadult 2 2/0 0 NA Adult 44 44/0 0 NA Unknown 3 3/0 0 NA Total 59 59/0 0 NA Kangerlussuaq Calf 5 5/0 0 2018 Subadult 11 11/0 1 0/1 Adult 23 22/1 1 0/1 Unknown 2 2/0 0 NA Total 41 40/1 2 0/2 Ivittuut Calf 2 2/0 0 NA 2018 Subadult 12 12/0 0 NA Adult 33 25/5 8 5/3 Unknown 8 8/0 0 NA Total 55 50/5 8 5/3 Winter Kangerlussuaq Calf 4 0/4 4 4/0 2017 Subadult 17 0/24 16 16/0 Adult 39 0/32 17 17/0 Unknown 18 0/18 6 6/0 Total 78 0/78 43 43/0 Total 233 149/84 53 48/5 Sheep Autumn Narsaq Lamb 29 0/29 30 30/0 2017 Adult 15 0/15 20 20/0 Total 44 0/44 50 50/0 Narsaq Lamb 0 NA 79 79/0 2018 Adult 0 NA 26 26/0 Total 0 NA 105 105/0 Total 44 0/44 155 155/0\nOpen in a separate window\na Muskox: calf < 1 year, subadult 1 and < 3, adult 3; sheep: lamb: < 1, adult 1.\nb Dropping/rectal.\n\nc Serum tube/filter paper.\n\nd Not applicable.\n\nSampled muskoxen were identified and their sex and age group were determined from a distance by telescope or binoculars based on the field guide by Olesen and Thing (1989).\n\nFaecal samples not assigned to specific individuals were marked as ‘unknown’.\n\nTo minimise the risk of re‐sampling, sampling was attempted to include different groups in different areas; however, because transportation was on foot, the reachable area was limited.\n\nFaecal samples were collected directly from the rectum of harvested muskoxen in MWG in winter 2017 and in SWG in summer 2018.\n\nAges and sexes of the sampled animals were estimated and recorded by hunters.\n\nSamples from sheep were collected in the autumn of 2017 at the abattoir in Narsaq from the distal colon or rectum of slaughtered sheep from at least 16 farms.\n\nEach faecal sample consisted of approximately 25 g faeces and was immediately transferred to a 50‐ml tube containing 30 ml 96% ethanol, with the exception of sheep samples, which were stored at 5°C for up to three days before adding of ethanol.\n\nThe Zackenberg samples and the Kangerlussuaq winter samples were stored at –18°C for up to 3 weeks and 1.5 years, respectively, prior to shipping.\n\nSamples were drained and stored wet in polystyrene boxes during transport to the University of Copenhagen, Denmark.\n\nMuskox samples collected during the summer in Kangerlussuaq and Ivittuut were stored cool under field conditions and sheep samples were stored at 5°C for up to 5 weeks until transport.\n\nUpon arrival at the University of Copenhagen all samples were stored in 96% ethanol at 5°C for up to 3 months until further processing.\n\n2.3.\n\nSamples for serology\nSamples for serology were collected from muskoxen (MWG and SWG) and sheep (SWG) in 2017 and 2018 (Table 1).\n\nBlood samples from the Kangerlussuaq population were collected at bleeding from the jugular vessels directly into 9‐ml serum tubes (VACUETTE, Serum Clot Activator, Greiner Bio‐One, Austria) 15–30 min after the animals were shot.\n\nSome of the samples collected during winter in MWG were obtained from carcasses 4–6 h post‐mortem, directly in a serum tube from the heart (if available), the thoracic cavity, or from the femoral blood vessels.\n\nBlood samples were collected from harvested muskoxen in SWG and MWG during the summer of 2018.\n\nSamples were collected at bleeding in serum tubes or on Nobutu filter paper strips (Toyo Roshi Kaisha, Ltd., Tokyo, Japan) as described by Curry et al.\n\n(2011).\n\nThe eluate retrieved from the filter paper samples were estimated to be 1:10 dilution of serum and serology protocols were adjusted accordingly (Curry et al., 2011).\n\nAt the abattoir in Narsaq, blood samples were collected from domestic sheep from at least 30 separate farms during the autumn of 2017 and 2018.\n\nAll samples were collected in serum tubes from the jugular vessels during bleeding.\n\nInformation on sex and age was noted.\n\nAll samples were kept from freezing during transport and stored at 5°C overnight or at room temperature for 2 h before centrifugation at approximately 1400 × g for 10 min.\n\nFilter paper samples were kept frozen for up to 4 months until further processing.\n\nAll samples were stored at –18°C for up to 3.5 years before analysis.\n\n2.4.\n\nPCR detection of Giardia and Cryptosporidium\nA subsample of each faecal sample was transferred to a 2‐ml Eppendorf tube and washed three times to remove residual ethanol by adding of phosphate‐buffered saline (PBS) and subsequent centrifugation at 2000 × g for 5 min.\n\nThe samples were subsequently subjected to DNA extraction.\n\nBriefly, approximately 100 mg of each washed sample was mixed with 260 μl Lysis Buffer in tubes containing 1.4‐mm Zirconium beads (OPS Diagnostics LLC, Lebanon, USA) and bead‐beaten in a TissueLyser II (QIAGEN, Germany) for 2 min at 30 Hz, followed by 8 min of incubation at room temperature, to release DNA from cysts and oocysts.\n\nSamples were then centrifuged at 1000 × g for a few seconds, and the entire supernatant was transferred with a 1000 μl pipette to a new Eppendorf tube and centrifuged for 5 min at 16,000 × g to sediment large particles.\n\nSubsequently, 100 μl of the supernatant from each sample was processed by the automated NucliSENS easyMAG (bioMérieux, France) platform according to the manufacturer's protocol.\n\nNo inhibition controls were included in the DNA extraction.\n\nExtracted DNA was stored at ‐20°C until further processing.\n\nFor detection of G. duodenalis and Cryptosporidium spp.\n\nDNA, we used the diagnostic duplex real‐time PCR in place at Statens Serum Institut, Copehagen, Denmark (Thomas‐Lopez et al., 2020).\n\nPrimers and probes used are listed in Table 2.\n\nThe 25 μl reaction mixture contained 0.2 μl IMMOLASE™ DNA Polymerase (Bioline), 5 μl 10 × ImmoBuffer (Bioline), 1.25 μl (1 μM) of each primer, 0.125 μl (0.075 μM) of each probe, 5 μl of DNA eluate and water sufficient to reach the total volume of 25 μl.\n\nNegative (water) and positive (G. duodenalis and C. parvum DNA), controls and inhibition controls were included in each run on the Applied Biosystems 7500 Fast Real‐Time PCR Thermocycler (Thermo Fisher Scientific, Denmark).\n\nPCR cycling conditions were as follows: 10 min at 95°C (initial denaturation), 50 cycles of 15 s at 95°C, and 60 s at 60°C.\n\nPCR products were analysed with the Sequence Detection Software v.2.3 (Thermo Fisher Scientific).\n\nSamples were considered positive if they exhibited a sigmoid growth curve with a threshold cycle value (Ct value) ≤ 37.\n\nSamples with a Ct value > 37 and ≤ 42 (read at ΔRn = 0.1) were considered borderline‐positive.\n\nTABLE 2\nPrimers and probes used for real‐time PCR for Giardia duodenalis and Cryptosporidium spp\nTarget organism/oligo name Sequences (5′–3′ direction) Reference Giardia duodenalis Giardia‐80F GACGGCTCAGGACAACGGTT Verweij et al.\n\n( 2004 ) Giardia‐127R TTGCCAGCGGTGTCCG Verweij et al.\n\n( 2004 ) Probe Giardia‐105T FAM‐CCCGCGGCGGTCCCTGCTAG‐BHQ‐1 Verweij et al.\n\n( 2004 ) Cryptosporidium spp.\n\nCRY F3 CTACACTGATGCATCCATCRAGT This study CRY R3 CCCATCACGATGCATAYTCAAAA This study Probe CRY P VIC‐TCCTGTTTCGAAGGAAATGGGTAATC‐MGB This study\nOpen in a separate window\n2.5.\n\nSubtyping of giardia and cryptosporidium\nDNA samples identified as positive for Cryptosporidium by real‐time PCR were subjected to species identification and genotyping.\n\nSpecies identification was performed by nested PCR targeting the SSU rRNA gene with outer primers SSU‐F2 and SSU‐R2 and the inner primers SSU‐F3 and SSU‐R3 after Xiao et al.\n\n(2019).\n\nGenotyping relied on the protocol originally described by 2003 targeting the gp60 gene.\n\nBriefly, the nested PCR used AL3531 and AL3535 as outer primers and AL3532 and AL3534 as inner primers.\n\nDNA samples identified as positive for Giardia were subjected to species identification and assemblage typing of Giardia by PCR of three loci: SSU rRNA, ‐giardin and tpi.\n\nBriefly, species identification (SSU rDNA analysis) was performed by single PCR with primers RH 11 and RH 4, while assemblage typing was conducted by nested PCR of the ‐giardin gene with the outer primers BG‐G7‐F and BG‐G759‐R and inner primers BF‐G376‐F and BG‐G759‐R according to Cacciò et al (2002).\n\nLikewise, a nested PCR of the tpi gene was conducted with AL3543 and AL3546 as outer primers and AL3544 and AL3545 as inner primers (Sulaiman et al., 2003).\n\nIf no samples were successfully genotyped based on the originally extracted DNA further isolation of cysts/oocysts was attempted using a sucrose gradient protocol modified from Faridi et al.\n\n(2020) and Lebbad et al.\n\n(2008) and subsequent subtyping.\n\nIn short, 3 g of faeces were homogenised with 8 ml PBS, and the solution was filtered through a double layer of gauze into a 50‐ml tube.\n\nThe tube was centrifuged at 400 × g for 5 min, and the supernatant was discarded.\n\nThe sediment was washed in 10 ml PBS with centrifugation at 1500 × g for 5 min and the supernatant was discarded.\n\nAfter addition of 7 ml PBS, the suspension was vortexed, and slowly—drop by drop—added on top of a 5°C sucrose solution (1 M) in a 15‐ml tube so that two distinct phases were formed.\n\nThe tube was centrifuged at 600 × g for 5 min.\n\nThe cloudy cyst‐containing layer between the sucrose and the faecal solution was transferred to a new 15‐ml tube with a Pasteur pipette.\n\nThe transferred material was washed four times in PBS with centrifugation at 1500 × g for 5 min in order to remove the sucrose from the cysts.\n\nThe supernatant was removed, and the remaining 1 ml sediment was transferred to a 2‐ml Eppendorf tube and stored at –20°C until DNA extraction, as previously described.\n\nSequences were obtained by bidirectional Sanger sequencing (Eurofins Genomics, Germany) and submitted to GenBank with the following accession numbers: {"type":"entrez-nucleotide-range","attrs":{"text":"MW980720-MW980724","start_term":"MW980720","end_term":"MW980724","start_term_id":"2083010137","end_term_id":"2083010145"}}MW980720-MW980724.\n\nForward and reverse sequences were assembled using Staden Package (https://sourceforge.net/projects/staden/), manually edited and consensus sequences compared with reference sequences in the GenBank database using the Basic Local Alignment Search Tool (BLAST).\n\nAll chromatograms were manually inspected for the presence of double peaks indicating mixed species/subtypes.\n\nFor Cryptosporidium, the CryptoGenotyper (Yanta et al., 2021), available on the web‐based platform Galaxy (Jalili et al., 2021), was used for initial Cryptosporidium genotyping and gp60 subtype were confirmed by manual identification of trinucleotide repeats as previously described (Chalmers et al., 2019).\n\nIf sequencing of DNA extracted from original faecal material or from cysts/oocysts isolated by the sucrose gradient method was not successful, no further attempts for characterisation were performed.\n\n2.6.\n\nSerology for Toxoplasma gondii\nThe sera were screened for T. gondii‐specific IgG antibodies using a commercially available modified direct agglutination test (DAT; Toxo‐Screen DA, bioMérieux, France), following the manufacturer's instructions, except that only 1:40 dilutions were used.\n\nAnimals that tested positive at the 1:40 dilution were considered seropositive and tested further at 12 threefold dilutions, from 1:6 to 1:162,000, to determine the antibody titres.\n\nPositive and negative controls provided in the kit were included on each plate, and the antigen was controlled for autoagglutination.\n\n2.7.\n\nSerology for Erysipelothrix\nSamples were screened for antibodies against Erysipelothrix according to Mavrot et al.\n\n(2020).\n\nWe used a conservative cut‐off value with only samples above the upper limit of the cut‐off confidence intervals (CI) considered positive.\n\nFor muskox samples we used the cut‐off values of 0.25% positivity (95% CI: 0.23%–0.28%) and 0.49% positivity (CI: 0.36%–0.59%) for serum and filter paper samples, respectively (Mavrot et al., 2020).\n\nFor sheep samples, we used a cut‐off value of 0.087% positivity (CI: 0.056%–0.162%) of a pig positive control.\n\nThe cut‐off values for sheep were established by a mixture‐distribution modelling approach (see Mavrot et al., 2020), using the sheep samples included in this study.\n\nAll plates included high‐, medium‐, and low‐positive controls and a negative control.\n\n2.8.\n\nStatistical analyses\nThe open‐source software for epidemiological statistics OpenEpi (Dean et al., 2013) was used to calculate prevalence estimates and Wilson score 95% CI for binomial data (Wallis, 2013).\n\nFisher's exact test (Kim, 2017) implemented in the statistical programming software R (v. 4.0.0) (R Core Team, 2019) was used to compare prevalence estimates by location, season and age groups.\n\np Values < 0.05 were considered to indicate statistical significance.\n\nGo to:\n3.\n\nRESULTS\n3.1.\n\nCopro‐prevalence of Giardia duodenalis and Cryptosporidium spp\nThe overall prevalence estimate of G. duodenalis was 3.0% (CI: 1.5%–6.1%) in muskoxen and 37.2% (CI: 24.4%–52.1%) in sheep.\n\nTwo samples—an adult muskox from Zackenberg and a lamb—were inconclusive due to inhibition in the real‐time PCR assay and were excluded from further analyses.\n\nFor muskoxen, DNA specific for G. duodenalis was identified in summer samples from Kangerlussuaq, but not in samples from Zackenberg, Ivittuut or winter samples (Table 3).\n\nAmong the summer samples from Kangerlussuaq, seven tested positive for G. duodenalis, resulting in an estimated prevalence of 17.1%.\n\nFour samples tested borderline‐positive for G. duodenalis.\n\nThere was a significantly higher prevalence of G. duodenalis in summer than in winter (p < 0.001).\n\nConsidering summer samples, the estimated prevalence of G. duodenalis in Kangerlussuaq was significantly higher than in Zackenberg (p = 0.002) and Ivittuut (p = 0.002).\n\nGiardia duodenalis‐positive muskoxen were found across all age groups.\n\nTABLE 3\nPrevalence of Giardia duodenalis and Cryptosporidium spp.\n\nin muskoxen (Ovibos moschatus) and sheep (Ovis aries) from Greenland by location, season and age group a\nGiardia duodenalis Cryptosporidium spp .\n\nSpecies/season/location/age group No.\n\nof animals tested No.\n\npositive % positive (CI b ) No.\n\npositive % positive (CI) Muskox Summer Zackenberg Calf 10 0 0.0 (0.0–25.9) 0 0.0 (0.0–25.9) Subadult 2 0 0.0 (0.0–77.6) 0 0.0 (0.0–77.6) Adult 43 0 0.0 (0.0–8.2) 0 0.0 (0.0–8.2) Unknown 3 0 0.0 (0.0–56.2) 0 0.0 (0.0–56.2) Total 58 0 0.0 (0.0–6.2) 0 0.0 (0.0–6.2) Kangerlussuaq Calf 5 1 20.0 (3.6–62.4) 1 20.0 (3.6–62.4) Subadult 11 3 27.3 (9.7–56.6) 0 0.0 (0.0–25.9) Adult 23 2 26.1 (12.6–46.5) 0 0.0 (0.0–14.3) Unknown 2 1 50.0 (9.5–90.6) 0 0.0 (0.0–65.8) Total 41 7 26.8 (15.7–41.9) 1 2.4 (0.4–12.6) Ivittuut Calf 2 0 0.0 (0.0–65.8) 1 50.0 (9.5–90.6) Subadult 12 0 0.0 (0.0–24.3) 0 0.0 (0.0–24.3) Adult 33 0 0.0 (0.0–10.4) 3 9.1 (3.1–23.6) Unknown 8 0 0.0 (0.0–32.4) 0 0.0 (0.0–32.4) Total 55 0 0.0 (0.0–6.5) 4 7.3 (2.9–17.3) Winter Kangerlussuaq Calf 4 0 0.0 (0.0–49.0) 0 0.0 (0.0–49.0) Subadult 17 0 0.0 (0.0–18.4) 0 0.0 (0.0–18.4) Adult 39 0 0.0 (0.0–9.0) 0 0.0 (0.0–9.0) Unknown 18 0 0.0 (0.0–17.6) 0 0.0 (0.0–17.6) Total 78 0 0.0 (0–4.7) 0 0.0 (0–4.7) Sheep Autumn Narsaq Lamb 28 16 57.1 (39.1–73.5) 1 3.6 (0.6–17.7) Adult 15 0 0.0 (0.0–20.4) 0 0.0 (0.0–20.4) Total 43 16 37.2 (24.4–52.1) 1 2.3 (0.4–12.1)\nOpen in a separate window\na Muskox: calf < 1 year, subadult 1 and < 3, adult 3; sheep: lamb: < 1, adult 1.\nb 95% confidence interval.\n\nFor sheep, 16 samples were positive for G. duodenalis‐specific DNA (all positive samples were from lambs, Table 3) and one lamb was borderline‐positive.\n\nThe prevalence in lambs was significantly higher than in adults (p < 0.001).\n\nThe attempt to genotype the Giardia parasites from the original faecal DNA extraction failed.\n\nTherefore, the four samples with lowest Ct‐values (Ct‐value < 30; two muskoxen from Kangerlussuaq and two sheep) were subjected to the sucrose gradient protocol and subsequent DNA extraction.\n\nThe parasites in one of these samples (a muskox from Kangerlussuaq) were successfully genotyped as Giardia duodenalis assemblage A based on results for all three loci (GenBank accession no.\n\n: {"type":"entrez-nucleotide-range","attrs":{"text":"MW980722-MW980724","start_term":"MW980722","end_term":"MW980724","start_term_id":"2083010141","end_term_id":"2083010145"}}MW980722-MW980724).\n\nHowever, no information on sub‐assemblage was available for the identical sequences in GenBank.\n\nThe ‐giardin PCR of the remaining samples was negative, and the tpi sequencing results were of mixed quality.\n\nWe were not able to characterise the three remaining samples using either gene.\n\nThe estimated prevalence of Cryptosporidium spp.\n\nwas 2.2% (CI: 0.9%–4.9%) in muskoxen and 2.3% (CI: 0.4%–12.1%) in sheep.\n\nIn addition, two samples—an adult muskox from Ivittuut and a lamb—were borderline‐positive.\n\nFor muskoxen, Cryptosporidium‐specific DNA was detected in samples collected during summer in Kangerlussuaq (2.4%) and Ivittuut (7.3%), but not in samples from Zackenberg nor in winter samples (Table 3).\n\nWithin samples from Kangerlussuaq, there was no statistically significant difference between the prevalence in summer and winter (p = 0.34).\n\nConsidering summer samples, no significant difference in the prevalence of Cryptosporidium was observed among the three populations; however, the prevalence tended to be higher in the Ivittuut population than in the Zackenberg population (p = 0.05).\n\nCryptosporidium‐positive samples were found in two calves and three adults, but not in subadult animals.\n\nFor sheep, one lamb was positive for Cryptosporidium DNA.\n\nThere was no significant statistical difference between the prevalence of Cryptosporidium in adults and lambs (p = 1).\n\nThe parasites in two of the eight Cryptosporidium‐positive samples, both from the Ivittuut muskox population, were identified as C. parvum IIdA20G1 by use of the CryptoGenotyper followed by manual analysis of the repeat region.\n\nManual evaluation of chromatograms and analysis successfully identified the parasites in both samples as C. parvum IIdA20G1 (GenBank accession no.\n\n: {"type":"entrez-nucleotide-range","attrs":{"text":"MW980720-MW980721","start_term":"MW980720","end_term":"MW980721","start_term_id":"2083010137","end_term_id":"2083010139"}}MW980720-MW980721).\n\nFollowing BLAST, the sequences were found identical to C. parvum IIdA20G1e reference sequences (GenBank accession no.\n\n: {"type":"entrez-nucleotide","attrs":{"text":"KU852714","term_id":"1073931883"}}KU852714 and {"type":"entrez-nucleotide","attrs":{"text":"FJ917375","term_id":"237690255"}}FJ917375).\n\nWe were not able to identify the species or genotype of the remaining samples positive by real‐time PCR.\n\n3.2.\n\nSeroprevalence of Toxoplasma gondii\nThe overall seroprevalence of T. gondii was 1.9% (CI: 0.3%–10.1%) in muskoxen and 0.6% (CI: 0.1%–3.6%) in sheep (Table 4).\n\nIn total, we found one antibody‐positive muskox (a yearling from Kangerlussuaq that was sampled in 2017), and one seropositive sheep (a lamb from SWG that was sampled in 2018) (Table 4).\n\nBoth of these samples had been collected in serum tubes during bleeding of the animals.\n\nWe did not detect antibodies against T. gondii in any of the tested samples from the Ivittuut muskox population (Table 4).\n\nTABLE 4\nToxoplasma gondii seroprevalence and Erysipelothrix seroprevalence in muskoxen (Ovibos moschatus) and sheep (Ovis aries) from Greenland by location and age group a\nToxoplasma gondii Erysipelothrix Species/location /age group No.\n\nof animals tested (ST/FP) b Positive (titre) % positive (CI c ) No.\n\nof animals tested (ST/FP) Positive % positive (CI) Muskox Total 52 (47/5) 1 1.9 (0.3–10.1) 53 (48/5) 2 3.8 (1.0–12.8) Kangerlussuaq Calf 4 (4/0) 0 0.0 (0.0–49.0) 4 (4/0) 0 0.0 (0.0–49.0) Subadult 17 (16/1) 1 (180) 5.9 (1.0–27.0) 17 (16/1) 0 0.0 (0.0–18.4) Adult 18 (17/1) 0 0.0 (0.0–17.6) 18 (17/1) 1 5.6 (1.0–25.8) Unknown 5 (5/0) 0 0.0 (0.0–43.5) 6 (6/0) 0 0.0 (0.0–39) Total 44 (42/2) 1 2.3 (0.4–11.8) 45 (43/2) 1 2.2 (0.4–11.6) Ivittuut Calf 0 NA d NA 0 NA NA Subadult 0 NA NA 0 NA NA Adult 8 (5/3) 0 0.0 (0.0–32.4) 8 (5/3) 1 12.5 (2.2–47.1) Unknown 0 NA NA 0 NA NA Total 8 (5/3) 0 0.0 (0.0–32.4) 8 (5/3) 1 12.5 (2.2–47.1) Sheep Total 155 (155/0) 1 0.6 (0.1–3.6) 150 (150/0) 10 6.7 (3.7–11.8) Narsaq Lamb 109 (109/0) 1 (162) 0.9 (0.2–5.0) 107 (107/0) 5 4.7 (2.0–10.5) Adult 46 (46/0) 0 0.0 (0.0–7.7) 43 (43/0) 5 11.6 (5.1–24.5)\nOpen in a separate window\na Muskox: calf < 1 year, subadult 1 and < 3, adult 3; sheep: lamb: < 1, adult 1.\nb Sampling method (serum tube/filter paper).\n\nc 95% confidence interval.\n\nd Not applicable.\n\n3.3.\n\nSeroprevalence of Erysipelothrix\nThe overall seroprevalence of Erysipelothrix was 3.8% (1.0%–12.8%) in muskoxen and 6.7% (3.7%–11.8%) in sheep (Table 4).\n\nA total of two adult muskoxen were seropositive—one from Kangerlussuaq sampled in a serum tube in winter 2017, and one from Ivittuut sampled on filter paper in summer 2018.\n\nAmong the sheep samples, no statistically significant difference between the estimated prevalence in adults and lambs was observed (p = 0.1).\n\nGo to:\n4.\n\nDISCUSSION\nOur study demonstrated that Cryptosporidium and Giardia duodenalis are circulating in muskox and sheep populations in west Greenland and that potentially zoonotic strains of G. duodenalis and C. parvum are present in muskoxen.\n\nSeveral species and genotypes of Giardia and Cryptosporidium have been recognised, but only some, as G. duodenalis assemblage A and C. parvum, appear to have zoonotic potential (Monis & Thompson, 2003; Ryan & Zahedi, 2019; Sprong et al., 2009; Thompson et al., 2008).\n\nThe clinical impact of Giardia and Cryptosporidium on free‐ranging muskox populations is unknown (Kutz et al., 2012), but infections in domestic sheep have been associated with diarrhoea and reduced slaughter weight (Ryan & Zahedi, 2019; Sweeny et al., 2011).\n\nDuring sample collection, the body condition of the animals was not recorded, and the potential health effect of infections to the host animal could, therefore, not be investigated in this study.\n\nOur difficulties related to genotyping may be related to the way in which the samples were handled and stored.\n\nThe use of ethanol as a fixative for long‐time storage of incompletely homogenised ruminant faecal pellets may have been insufficient for preventing the DNA from degrading (Kuk et al., 2012), leaving the DNA of sufficient quality for real‐time PCR (< 100 base pair [bp] products) but unsuitable for longer PCR products used for genotyping (e.g.\n\n700 bp).\n\nAnother reason for the challenges in the genotyping work may be the high Ct‐values observed for many of the samples, indicating low levels of DNA present.\n\nHowever, genotyping failed even for some of the samples with Ct‐values < 25.\n\nThe finding of G. duodenalis assemblage A in one Greenland muskox is consistent with typing studies of G. duodenalis in muskoxen from Canada and Norway (Davidson et al., 2014; Kutz et al., 2008).\n\nBabbott et al.\n\n(1961) microscopically identified G. duodenalis (cited as G. lamblia) in humans from Aasiaat in west Greenland, which indicates that it may have been circulating there at least since the 1950s.\n\nCryptosporidium appears to be relatively uncommon in Arctic wildlife, though reported in low prevalence in caribou from Canada (Jenkins et al., 2013; Johnson et al., 2010; Kutz et al., 2012) and Norwegian muskoxen (Davidson et al., 2014).\n\nReports on C. parvum in free‐ranging wild ungulates are limited (Sturdee et al., 1999; Duszynski & Upton, 2001) and the IIdA20G1e subtype was hitherto only reported from Sweden in young cattle and in a food‐borne outbreak of cryptosporidiosis (Gherasim et al., 2012; Silverlås et al., 2010; SVA, 2019).\n\nOur DNA sequences were identical to reference sequences from Sweden (Silverlås et al., 2010), while differing by one bp from DNA sequences obtained from, for example humans from Israel (GenBank accession no.\n\n: {"type":"entrez-nucleotide","attrs":{"text":"MK095329","term_id":"1531254309"}}MK095329, {"type":"entrez-nucleotide","attrs":{"text":"MK095314","term_id":"1531254279"}}MK095314) and Egypt (GenBank accession no.\n\n: {"type":"entrez-nucleotide","attrs":{"text":"KX397563","term_id":"1078716847"}}KX397563, {"type":"entrez-nucleotide","attrs":{"text":"KX443783","term_id":"1043489755"}}KX443783), and from Chinese cattle (GenBank accession no.\n\n: {"type":"entrez-nucleotide","attrs":{"text":"KU248815","term_id":"1026817939"}}KU248815).\n\nThe prevalence of anti‐T.\n\ngondii antibodies observed in this study was relatively low compared with prevalence estimates from Canadian muskoxen (6%) (Kutz et al., 2000) and pooled seroprevalence estimates from sheep from the Nordic‐Baltic region (23%) (Olsen et al., 2019).\n\nEarlier seroepidemiological studies on T. gondii in wild ungulates from Greenland failed to document seropositive animals (Carlsson et al., 2019; Clausen & Hjort, 1986; Kutz et al., 2012).\n\nFor sheep, the only available reference is a conference abstract (Bille, 1974) mentioning the possible findings of antibodies against T. gondii in sheep from SWG, however, a later source (Clausen & Hjort, 1986) states that the animals were seronegative.\n\nThe method used in this study has been widely used for different animal species (Dubey 2010); however, the use of a confirmatory method could have reduced the risk of generating false positive results.\n\nStill, the cut‐off for seropositivity we used can be considered relatively high, while the determination of titres supported the positive findings.\n\nTo reduce the risk of false negatives due to the prozone phenomenon, a 1:4000 dilution of serum could have been included in addition to the 1:40 dilution used.\n\nAdding to the findings of T. gondii seropositive polar bears (Ursus maritimus) from NEG (Oksanen et al., 2009), our results suggest that animals in Greenland are exposed to T. gondii, albeit at a relatively low rate.\n\nHowever, the source of the exposure remains unclear.\n\nIn the absence of wild felids and because of the low number of domestic cats (Felis catus domesticus), migratory birds and marine mammals have been suggested as plausible reservoirs and sources of T. gondii in the Arctic (Jenkins et al., 2013; Kutz et al., 2012; Prestrud et al., 2008).\n\nDomestic cats are used for rodent control on sheep farms in SWG, but the current number of cats and the T. gondii prevalence in the cat population in Greenland is unknown.\n\nToxoplasma gondii can cause clinical disease and abortions in domestic sheep (Dubey, 2009).\n\nFurthermore, T. gondii has been isolated from the placenta of a captive muskox following abortion (Crawford et al., 2000), and T. gondii has, therefore, been considered a potential factor contributing to population declines in North American muskox populations (Kutz et al., 2000).\n\nHowever, the low prevalence observed in this study indicates that the population health impact of T. gondii in ungulates from Greenland is presently not a concern.\n\nIn recent years, E. rhusiopathiae has been associated with mass mortality events in North American muskox populations (Forde et al., 2016; Kutz et al., 2015; Mavrot et al., 2020).\n\nThe seroprevalence study by Mavrot et al.\n\n(2020) indicates that E. rhusiopathiae has been circulating in the North American muskox populations, with fluctuating seroprevalence, at least since the 1970s.\n\nThe importance of E. rhusiopathiae to muskox population health in Greenland remains unknown, although the observed prevalence of Erysipelothrix is low compared to that observed during years of high muskox mortality in North America.\n\nThis suggests that Erysipelothrix may not currently be a health concern for the muskox population, but that it should be monitored, as studies in North America have shown considerable inter‐annual variability.\n\nErysipelothrix sp.\n\nhas previously been reported in faecal microbiome studies from NEG and the Canadian Arctic (Andersen‐Ranberg et al., 2018; Bird et al., 2019).\n\nIn sheep, especially lambs, E. rhusiopathiae can lead to significant disease with impact on animal welfare and economic loss from abortions, reduced growth rate, and condemnation of products at the abattoir (Ersdal et al., 2015; Fthenakis et al., 2006).\n\nOur study demonstrates that muskoxen and sheep from Greenland are infected with or exposed to several zoonotic pathogens with possible seasonal, geographical, and interspecies differences.\n\nThe observed relatively low prevalence of the selected zoonotic pathogens in muskoxen and sheep is reassuring but their presence in Greenland may have relevance to animal health and public health.\n\nThe limitations of this study include the limited sample size and that part of the samples were collected from hunted and slaughtered animals and may be biased by age, sex, and fitness.\n\nRegarding the sheep samples, the findings may not be representative for all sheep farms in Greenland, because samples from only a limited number of farms were included.\n\nOur results expand our knowledge of the diversity of zoonotic pathogens in wildlife and domestic sheep in Greenland.\n\nMuskoxen are known to be susceptible to pathogens mainly recognised in other host species (Kutz et al., 2004, 2008; Samuelsson et al., 2013; Tomaselli et al., 2016) and are relatively sedentary animals (Schmidt et al., 2016).\n\nMuskoxen could serve as an indicator of the presence of zoonotic pathogens in the environment in Greenland.\n\nMuskoxen are hunted annually and samples from the harvested individuals could be tested to monitor the emergence, presence and prevalence of zoonotic pathogens that can infect both animals and humans.\n\nWe identified potential geographic and seasonal differences that may inform future monitoring and research efforts that seek to further define the circulation of these pathogens in wildlife and domestic animals in the Greenland environment and characterise the risks of pathogen exchange among people, wildlife, and domestic animals.\n\nThe relative simplicity of the Arctic ecosystem allows the study of separate aspects of pathogen epidemiology and could thereby be a useful model for understanding the transmission patterns also in other, more complex, regions.\n\nGo to:\nAUTHOR CONTRIBUTIONS\nRebecca P. K. D. Berg: Conceptualisation, data curation, formal analysis, funding acquisition, investigation, project administration, resources, visualisation, writing‐original draft.\n\nC. Rune Stensvold: Data curation, funding acquisition, investigation, resources, validation, writing‐review and editing.\n\nPikka Jokelainen: Data curation, funding acquisition, investigation, resources, validation, writing‐review and editing.\n\nAnna K. Grønlund: Investigation, writing‐review and editing.\n\nHenrik V. Nielsen: Data curation, funding acquisition, resources, validation, writing‐review & editing.\n\nSusan Kutz: Data curation, funding acquisition, resources, validation, writing‐review and editing.\n\nChristian M. O. Kapel: Conceptualisation, funding acquisition, project administration, supervision, writing‐review and editing.\n\nGo to:\nCONFLICT OF INTEREST\nThe authors declare that they have no conflict of interests.\n\nPEER REVIEW\nThe peer review history for this article is available at https://publons.com/publon/10.1002/vms3.599\nGo to:\nACKNOWLEDGEMENTS\nWe gratefully acknowledge the Greenland Research Council and the Danish Government for funding through ‘Danish State funding for Arctic Research’ (grant no.\n\n: 80.19).\n\nThe project was also partly supported by ‘Den Grønlandske Fond’ (J. no 2016–557).\n\nLaboratory work and analyses conducted at the University of Calgary, Canada, were supported by grants from ‘Polar Knowledge Canada’ and ‘NSERC Discovery’ to SK.\n\nPJ, CRS and HVN are part of the TOXOSOURCES and PARADISE consortia, supported by funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No.\n\n773830: One Health European Joint Programme.\n\nWe are grateful for the field assistance from Bolethe Skifte Egede, Larissa Beumer, Sascha Schiøtt, Maia Olsen and local hunting officers and hunters from Arsuk and Kangerlussuaq.\n\nFurthermore, we thank the Neqi A/S abattoir in Narsaq and the veterinarians for support with sample collection from sheep.\n\nWe thank Angela Schneider and Fabien Mavrot from the University of Calgary for their invaluable help with Erysipelothrix laboratory work and analysis, Karl Zinglersen from the Greenland Institute of Natural Resources for input to graphics, and Ellinor Marving for assistance with implementation of the Cryptosporidium real‐time PCR.\n\nWe are also grateful to the staff at Zackenberg research station for logistic support during the fieldwork.\n\nGo to:\nNotes\nBerg, R. P. K. D. , Stensvold, C. R. , Jokelainen, P. , Grønlund, A. K. , Nielsen, H. V. , Kutz, S. , & Kapel, C. M.O.\n\n(2021).\n\nZoonotic pathogens in wild muskoxen (Ovibos moschatus) and domestic sheep (Ovis aries) from Greenland.\n\nVeterinary Medicine and Science, 7, 2290–2302.\n\n10.1002/vms3.599 [PMC free article] [PubMed] [CrossRef] [Google Scholar]\nGo to:\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer

  12. Assistant

    报告:格林兰野生麝牛(Ovibos moschatus)和家羊(Ovis aries)中的人畜共患病原体研究

    本研究旨在估计格林兰野生麝牛和家羊中四种人畜共患病原体的流行率,包括Giardia duodenalis、Cryptosporidium spp.、Toxoplasma gondii和Erysipelothrix rhusiopathiae。研究在2017和2018年期间进行,收集了来自三个不同种群的麝牛粪便样本以及来自西南格林兰的家羊样本。

    研究结果显示,G. duodenalis在Zackenberg、Kangerlussuaq和Ivittuut的麝牛中的流行率分别为0%、17%和0%,而在家羊中为37%。Cryptosporidium spp.在麝牛中的流行率为0%、2%和7%,在家羊中为2%。冬季样本中未检测到Giardia或Cryptosporidium。T. gondii的血清流行率在Kangerlussuaq的麝牛中为2%,在Ivittuut为0%,而在家羊中为1%。Erysipelothrix的血清流行率在Kangerlussuaq的麝牛中为2%,在Ivittuut为13%,在家羊中为7%。

    本研究为北极地区人畜共患病原体的知识提供了重要补充,尤其是在格林兰的生态系统中。研究表明,麝牛和家羊可能是多种人畜共患病原体的宿主,且这些病原体的存在可能对动物健康和公共健康产生影响。

    Erysipelothrix rhusiopathiae是一种全球分布的病原体,通常在猪、家禽和人类中引起机会性感染,并且在绵羊中常见导致多关节炎的病例。其传播途径主要通过接触污染的材料或土壤。近年来,E. rhusiopathiae与北美麝牛的死亡事件相关联,其在北极野生动物中的存在被认为是一个潜在的公共健康问题。

    综上所述,本研究扩展了对格林兰野生动物和家羊中人畜共患病原体多样性的了解,强调了对这些病原体的监测和研究的重要性,以评估其对动物和人类健康的潜在风险。

    [End of Notes, Message #6] {{{ I_finished_papa!!! }}}